Omega-3 fatty acids ameliorate cognitive dysfunction in schizophrenia patients with metabolic syndrome Digest

From the publication:

We hypothesized that omega-3 fatty acids may be of value in improving cognitive dysfunction and enhancing BDNF levels in schizophrenia patients with metabolic syndrome.

You just missed this in your inbox

Every other week our Premium Members received this exact study plus Rhonda's practical commentary and 8+ other hand-picked papers.

Get the next issue →

[…]

There was a significant correlation between omega-3 fatty acid treatment and improved delayed memory.

Omega-3 fatty acids enhanced brain-derived neurotrophic factor levels after 12 weeks of treatment through suppressing TNF- levels.